Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $23.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 202 | $23.02M | Healthcare | Pharmaceuticals | United States | NYSE |
| 203 | $22.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 204 | $22.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 205 | $21.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 206 | $20.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 207 | $20.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 208 | $19.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 209 | $19.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $19.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 211 | $19.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 212 | $18.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 213 | $18.73M | Healthcare | Pharmaceuticals | United States | NYSE |
| 214 | $18.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 215 | $17.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 216 | $17.24M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 217 | $17.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 218 | $16.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 219 | $16.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 220 | $16.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 221 | $15.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 222 | $15.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 223 | $15.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $15.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 225 | $15.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 226 | $15.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 227 | $14.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 228 | $13.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 229 | $13.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 230 | $13.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 231 | $13.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 232 | $13.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 233 | $12.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 234 | $12.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 235 | $12.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 236 | $12.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 237 | $12.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 238 | $12.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 239 | $11.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 240 | $11.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 241 | $11.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 242 | $11.33M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 243 | $11.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 244 | $10.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 245 | $10.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 246 | $10.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 247 | $10.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 248 | $10.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $9.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 250 | $9.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 251 | $9.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 252 | $9.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 253 | $9.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 254 | $9.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 255 | $8.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $8.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 257 | $8.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 258 | $8.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 259 | $8.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 260 | $8.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 261 | $8.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $7.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $7.89M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 264 | $7.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 265 | $7.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 266 | $7.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 267 | $7.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 268 | $7.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 269 | $7.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 270 | $7.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 271 | $6.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 272 | $6.86M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 273 | $6.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 274 | $6.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 275 | $6.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 276 | $5.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 277 | $5.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $4.87M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 279 | $4.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 280 | $4.43M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 281 | $4.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 282 | $4.12M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 283 | $3.86M | Healthcare | Pharmaceuticals | United States | NYSE |
| 284 | $3.79M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 285 | $3.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 286 | $3.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 287 | $3.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 288 | $3.43M | Healthcare | Pharmaceuticals | United States | NYSE |
| 289 | $3.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 290 | $3.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 291 | $2.94M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $2.70M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 293 | $2.63M | Healthcare | Pharmaceuticals | United States | NYSE |
| 294 | $2.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 295 | $2.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 296 | $2.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 297 | $2.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 298 | $1.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 299 | $1.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 300 | $1.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 317 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.